Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Walgreens slashes dividend even as Q1 profit beats estimates

by Jessica Weisman-Pitts
0 comment

Walgreens slashes dividend even as Q1 profit beats estimates

(Reuters) -U.S. pharmacy chain Walgreens Boots Alliance on Thursday nearly halved its dividend to save more money, even as the company’s cost-cut measures helped it report better-than-expected quarterly profit.

Higher drug prices also boosted the pharmacy operations of the company that has been grappling with fierce competition, sharply lower sales from COVID vaccines and testing, and decreased discretionary spending by inflation-weary consumers.

The company was forced to close unprofitable stores and cut jobs to reduce costs in a tough environment.

Walgreens first-quarter performance reflects “disciplined execution in a challenging consumer backdrop,” said CEO Tim Wentworth.

Wentworth said the company was evaluating all strategic options and focusing “on swift actions to right-size costs and increase cash flow.”

The healthcare industry veteran was appointed in October to take the reigns of the company, which has been looking to emerge from the troubles surrounding it and expand its footprint in healthcare services.

Shares of the Deerfield-Illinois based company rose more than 2% in premarket trading on Thursday as Walgreens cut quarterly dividend by 48% to 25 cents per share.

The dividend cut could help “shore up” Walgreens’ balance sheet and save about $800 million on an annual basis, Evercore analyst Elizabeth Anderson said.

Walgreens, which has been shifting its focus on healthcare services from pharmacy, reiterated its profit forecast of $3.20 to $3.50 per share in fiscal 2024.

Evercore’s Anderson said this was an “upside surprise” for investors.

The healthcare services unit, however, missed first-quarter revenue estimates. It reported revenue of $1.93 billion compared with estimates of $2.03 billion, according to LSEG data.

Walgreens’ U.S. retail pharmacy unit brought in revenue of $28.94 billion, above estimates of $27.26 billion. Same-store sales at its U.S. pharmacies jumped 13.1% year-over-year.

On an adjusted basis, the company earned 66 cents per share, compared with estimates of 61 cents per share.

(Reporting by Bhanvi Satija and Mariam Sunny in Bengaluru; Editing by Shinjini Ganguli)